首页>
外国专利>
RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF PROVASOPRESSIN OR FRAGMENTS AND PARTIAL PEPTIDES THEREOF, IN PARTICULAR COPEPTIN OR NEUROPHYSIN II
RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF PROVASOPRESSIN OR FRAGMENTS AND PARTIAL PEPTIDES THEREOF, IN PARTICULAR COPEPTIN OR NEUROPHYSIN II
展开▼
机译:血管紧张素Ⅱ或其片段和部分肽对特定冠蛋白或神经PHYS的急性冠状动脉综合征的危险分层II
展开▼
页面导航
摘要
著录项
相似文献
摘要
PROBLEM TO BE SOLVED: To provide a method for risk stratification for acute coronary syndrome (ACS), in particular acute myocardial infarction (AMI) and angina pectoris (AP), wherein provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, is determined by an in-vitro diagnosis.;SOLUTION: Provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, which has high sensitivity and specificity for the diagnosis of acute coronary syndrome is determined by an in-vitro diagnosis.;COPYRIGHT: (C)2013,JPO&INPIT
展开▼